UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Sillajen to expand clinical design for Pexa-Vec in US
Sillajen and its U.S. partner, Regeneron Pharmaceuticals, will expand the c...
by Lee Han-soo
|
2020-03-05 15:57
라인
Hanmi’s NASH treatment wins orphan drug status
Hanmi Pharmaceutical said that the U.S. Food and Drug Administration has gr...
by Lee Han-soo
|
2020-03-05 14:45
라인
GC gets item license from regulator
GC Pharma said Wednesday that it has won the chickenpox vaccine Varicella s...
by Shim Hyun-tai
|
2020-03-04 17:21
라인
JW Creagene wins patent to make dendritic cell treatment
JW Creagene, a subsidiary of JW Shinyak, said that it has registered a pate...
by Lee Han-soo
|
2020-03-04 17:20
라인
US attorney says Daewoong used Medytox's BTX strain
A staff attorney at the U.S. International Trade Commission (ITC) recently ...
by Lee Han-soo
|
2020-03-04 15:55
라인
Korea nods testing remdesivir in COVID-19 patients
The Ministry of Food and Drug Safety said it has approved Gilead Sciences’ ...
by Kim Yun-mi
|
2020-03-04 13:46
라인
GSK loses out to local drugmakers in quadrivalent flu vaccine sales
GSK’s sales of Fluarix Tetra, a vaccine against four different strains of i...
by Jeong Sae-im
|
2020-03-04 12:05
라인
ImmuneMed tests new drug candidate VSF on COVID-19 patients
ImmuneMed said the company and Seoul National University Hospital (SNUH) ha...
by Shim Hyun-tai
|
2020-03-03 16:59
라인
US firm to test potential coronavirus vaccine mRNA-1273
Gilead’s remdesivir is emerging as the first treatment of the new coronavir...
by Kim Yun-mi
|
2020-03-03 15:29
라인
Whanin to sell Gedeon Richter’s schizophrenia treatment
Whanin Pharmaceutical said that it would exclusively market Cariprazine, a ...
by Lee Han-soo
|
2020-03-02 16:55
라인
[Special] Allergan’s dominance at stake in Daewoong-Medytox BTX battle
Why did Allergan team up with Medytox?Medytox and Allergan became partner f...
by Park Gi-taek
|
2020-03-02 14:43
라인
Kainos Med’s HIV drug enters final stage of phase-3 trial
Kainos Medicine said Friday that its HIV drug KM-023 has entered into the f...
by Shim Hyun-tai
|
2020-02-28 17:07
라인
GSK, Clover collaborate on research for COVID-19 vaccine candidate
GSK said Friday that it has begun to collaborate with Clover Biopharmaceuti...
by Shim Hyun-tai
|
2020-02-28 12:25
라인
Hanmi, GC to co-develop rare diseases treatments
Hanmi Pharmaceutical and GC said on Thursday that they will cooperate in de...
by Lee Han-soo
|
2020-02-27 16:50
라인
JW Shinyak launches new hand eczema treatment
JW Shinyak, a subsidiary of JW Holdings, said on Thursday that it has launc...
by Lee Han-soo
|
2020-02-27 16:50
라인
FDA OKs 2 phase-3 clinical trials for Gilead's Remdesivir
Gilead Sciences said Wednesday that it has begun two phase-3 clinical trial...
by Shim Hyun-tai
|
2020-02-27 16:08
라인
Alvogen Korea wins anti-bribery system certification
Alvogen Korea said that it has acquired the ISO37001, an anti-bribery manag...
by Lee Han-soo
|
2020-02-27 12:10
라인
Huons Global posts ₩449.4 billion in 2019 sales
Huons Global said that it posted 449.4 billion won ($369.5 million) in sale...
by Lee Han-soo
|
2020-02-26 16:15
라인
US begins to test remdesivir for COVID-19 treatment
Following China, the U.S. has begun a clinical trial on remdesivir, Gilead’...
by Kim Yun-mi
|
2020-02-26 15:21
라인
Novo Nordisk’s Saxenda remains at top in obesity treatment sales
Novo Nordisk Korea said Thursday that its obesity treatment injection, Saxe...
by Shim Hyun-tai
|
2020-02-25 18:12
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top